Member Info for Stach

Hi there.What is not always appreciated,the Company's progress to the main Market is also stifled,yet the Government of yester-years decided to create AIM in order to help small Companies and small/big investors to grow together and enter the main Market eventually.The greed of some individuals is not allowing them to just make profits on the spread between buy/sell(which often is huge) and they want more.Why on earth this has not been sorted out by now by successive governmental regulatory bodies? Stach

BawlOfFruit.You just look at yesterday's trades.MMs were fleecing the small time investors by trying to scare them with ever dropping share price resulting in small but multiple sells.The big boys cleared the lot.This is what I am about,an unfairness of mms system on AIM.In a 21st Century and computer programs of today,there is no need for them.Other Countries do not have them.Its an anachronism.I said that before.This share dealings is worth remembering.Stach

Everybody is amazed at the phenomenal RNS and profits for ELA,except the mms.Fantastic case to present to FCA(showing how AIM does no good to small Firms and their genuine small investors).Stach

What a fantastic RNS ! Market makers do not wish to read it.Who needs mms,a complete waste of time.Stach

Hi.I am sorry to be late with my reply to your posts but I had an appointment with someone in my house this morning.I truly believed that MMs will jack up share price to around 150p after an exceptional RNS as we have had yesterday.It really pi..ed me off their behaviour. How could they justify 140p/share few weeks ago and then dropping to below 120p without any adverse news?You are quite correct that the Broker target was 170p,now reiterated twice.After a terrific news yesterday you would have thought that 150p at least would be fair trading price.Lets see if they gradually will bring it to that level.Longer term I see this reaching 200p+.Stach

Good morning.It looks as mms are carrying on as nothing happened yesterday ie an excellent RNS swept under the carpet.Have they not made enough money elsewhere to buy here? Stach

Do not laugh,soon we shall not be able to say "black market" without being arrested! It really shambles these days.My MP when approached just ignored any action by himself,referring me to FCA.It was to much bother for him to raise it in House of Commons.Stach

...Just gone through,that 25 minutes it took.I am just adding another 4500 shares(if it is possible).Today is a good example of killing the market by keeping the share price suppressed.This is not a "free market" it is an anathema of it.Stach

just put an order for 500 shares via NT to see how long it will take HH to conclude it.So you have it,no shares available to buy but any number you can sell.However the share price is frozen! Who wants mms in this business?No other Western Markets have them.Stach

NT even on1500 shares.The Market Size supposed to be 3000 ! It makes you laugh.Share price has not badged since morning.Draw your own conclusions about "collusion" ! Stach

That lot are short on money and once they make it elsewhere will be buying cheaply here and when fully loaded,push the price above 150p.Watch this space.They have done that not long ago,exactly that and when the share price reached 140p started their sells.It seems,we can not say a bad word here about mms.Stach

would not allow me to post criticism of the mms where I have pointed out the Broker rating at 170p just a month ago with buy recommendation in anticipation of the RNS like today's.In addition with sea of blue and no sells,mms lowering the share price! I said that the Gov should end this unfair system if they wish the small firms to prosper.Amazing how people are deprived of being able to say in normal english,what they feel!

The real share price is atm,16p - 18.5p with 17.8p quoted.Stach

Do not worry at all.Everything is going according to plan and expectations.Market Makers are trying to load up their accounts with cheaper shares as much as they can before good news arrives.Just hold on or do as they are doing and you will be pleased with yourself very soon.Stach

playing a blinder! Preparing themselves for tomorrow.How unfair to so many investors here.Stach

Good morning.I have replied to your last post but for unknown reason to me ,my post has been removed.I did get a phone call from ELA office late yesterday reassuring me that all is fine but sometimes MER-Test takes longer as we have to stick to the strict guidelines laid down by the Nigerian Authorities.ELA will inform the market shortly.No price sensitive info was given.Stach

ValJu,you have got not a clue about research of drugs,their clinical trials or commercial transition yet you clatter this bb with incessant ramping day after day.It seems to me that you are just building up your number of posts,just like a 11 years old would do.You are filtered as it will be so much easier to view this bb.Stach

As promised here,I have tried to speak to GM but his PA said he is out of the Country.Someone else was going to phone me yesterday but no phone call received.It is no good talking about 4000-6000 boo/d for Opuama10 within last three rnss and a total silence on MER-Test,which is crucial.I wished to invest more but will not do so till we get that message.Stach

You should re-read the rns.The only completed phase II TRIAL for VAL-401 is in adenocarcinoma of the lung.It is only that will be the qualifying clinical condition for phase III. In Georgia it may be different but I doubt it. Stach

It is very rare to have "partners"(you use plural) to support ANY drug in clinical trial.You make an agreement with one of your choice and that Pharma then finances the whole cabal associated with the trial.You can imaging the mess that you would have at the end of the unsuccessful period or suspension of the trial because of serious harm to the patients.The Health Trusts in this Country and in most of Europe would not agree to the multiple "ownership" of the Trials.It is also more difficult to agree on the Protocol for the Investigation and subsequent supervision,contacts with the treating doctors,patients and families of the patients.Data collection(and sometimes manipulation) is another story! Finally,compensation(if needed) can also be a problem(who is responsible for what? ).VAL,I am sure will have just one partner with enough money to finance the lot.By now they should know,who it is if they are projecting dosing first patient with VAL-401 in 2019.Stach